COMMUNIQUÉS West-GlobeNewswire

Align Technology Reaches 6 Millionth Invisalign® Patient Milestone With Tween Patient From China
18/12/2018
12-year old Yuzhe Wang from Beijing, China is in treatment with Invisalign trained doctor Jiawei Wo using Invisalign Comprehensive with Mandibular Advancement Accelerating adoption of Invisalign clear aligner treatment [...]
Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services
18/12/2018
Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance [...]
Medexus annonce la nomination d’un nouveau chef de la direction, d’un nouveau président du conseil d’administration, d’autres mises à jour organisationnelles et des attributions d’actions incitatives
18/12/2018
MONTRÉAL, 17 déc. 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (anciennement Pediapharm Inc.) (la « société ») (TSXV : PDP, OTCQB : PDDPF) a annoncé aujourd’hui des changements organisationnels visant à [...]
FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
18/12/2018
China is the first country to approve roxadustat First-in-class roxadustat offers a new, effective oral treatment SAN FRANCISCO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced that [...]
Nemaura Medical Announces Proposed Public Offering
17/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
Flexion Therapeutics Submits Supplemental New Drug Application (sNDA) for ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
17/12/2018
sNDA aims to revise the product label with new data indicating repeat administration of ZILRETTA was safe and well tolerated BURLINGTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) [...]
PhaseBio Appoints Edmund P. Harrigan to Board of Directors
17/12/2018
MALVERN, Pa. and SAN DIEGO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
EyePoint Pharmaceuticals Added to NASDAQ Biotechnology Index
17/12/2018
WATERTOWN, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Mid-Valley Hospital and clinic select Cerner CommunityWorks to enhance patient care
17/12/2018
10-year agreement aims to use Cerner to advance health strategy OMAK, Wash., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Mid-Valley Hospital (MVH) has selected Cerner, a global leader in health care technology, to transform its [...]
Inspire Medical Systems, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/12/2018
MINNEAPOLIS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)
17/12/2018
Mechelen, Belgium; 17 December 2018, 22.15 CET - Galapagos NV (Euronext & NASDAQ: GLPG) today announces that it has dosed its first patient in the worldwide ISABELA Phase 3 program with autotaxin inhibitor GLPG1690 [...]
Emergent BioSolutions Receives Health Canada Approval of BioThrax® (Anthrax Vaccine Adsorbed)
17/12/2018
GAITHERSBURG, Md., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its anthrax vaccine, BioThrax ® ( [...]
Rubius Therapeutics Added to Nasdaq Biotechnology Index
17/12/2018
CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, today announced that the company [...]
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update
17/12/2018
ACH-4471, First Generation Oral factor D Inhibitor - Proof of Concept Validated in both PNH as Monotherapy and in Combination w/C5 Inhibitor - Proof of Mechanism Validated in C3G, End of Phase 2 Meeting Targeted for 4Q [...]
Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials
17/12/2018
Conference call to be held and accompanying slide deck with photos to be included with Current Report on Form 8-K WAYNE, Pa., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist- [...]
CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
17/12/2018
BRISBANE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]
Principia Biopharma Issues Statement About the Passing of Board Member Lewis J. Shuster
17/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants
17/12/2018
MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “ Company ”) (TSXV: PDP, OTCQB: PDDPF) today announced organizational changes designed to better position the [...]
United Health Products to Hold Conference Call on December 20, 2018 to Discuss Recent Corporate Developments and Provide Year End Update
17/12/2018
HENDERSON, Nev., Dec. 17, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), a manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]

Pages